Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/12/2024 | $6.50 → $4.00 | Overweight → Underweight | Barclays |
| 11/14/2023 | $7.00 → $6.50 | Equal Weight → Overweight | Barclays |
| 5/18/2023 | Buy → Neutral | BofA Securities | |
| 6/1/2022 | $12.00 | Equal Weight | Barclays |
| 2/14/2022 | $9.00 → $10.00 | Equal-Weight | Morgan Stanley |
| 12/6/2021 | $7.00 → $9.00 | Equal-Weight | Morgan Stanley |
TEL AVIV, Israel, Nov. 21, 2024 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its third quarter results for the period ending September 30, 2024. Selected Financial Figures for the Third Quarter 2024: $m Q3/24 Q3/23 ILCO share in ICL profit1 49 59 Financing income, G&A and other expenses at ILCO headquarter level - (1) Tax income of ILCO Headquarters - - Net profit to company's shareholders 49 58 Liquidity at the ILCO Headquarters Level2 As of September 30, 2024, total financial liabilities were $722 million, and investments in liquid assets amounted to $843 million of which $313 million are pledged deposits. Net cash1 as of September 30, 2024, totaled $84
Continued to deliver sequential growth, with sales of $1.8 billion and adjusted EBITDA of $383 million Raising guidance for specialties-driven businesses ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2024. Consolidated sales were $1.75 billion versus $1.86 billion in the prior year. Operating income was $214 million, with adjusted operating income of $243 million, versus $227 million of operating income in the third quarter of last year. Adjusted EBITDA was $383 million versus $346 million. Diluted earnings per share were $0.09, with adjusted diluted EPS of $0.11, versus $0.11 in the
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2024 results prior to the opening of the TASE market on Monday, November 11, 2024. On that day, Raviv Zoller, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 225-9448, or (203) 518-9708 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employee
6-K - ICL Group Ltd. (0000941221) (Filer)
6-K - ICL Group Ltd. (0000941221) (Filer)
6-K - ICL Group Ltd. (0000941221) (Filer)
Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously
Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously
BofA Securities downgraded ICL Group from Buy to Neutral
SC 13G/A - ICL Group Ltd. (0000941221) (Subject)
SC 13G - ICL Group Ltd. (0000941221) (Subject)
SC 13G/A - ICL Group Ltd. (0000941221) (Subject)
Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps
Company hosts top food industry customers for innovation workshop and other events ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has opened a new food specialty plant in China, which was designed to help customers easily partner with ICL to create novel and innovative food offerings tailored to Chinese consumers' palates. The facility will manufacture specialty food solutions in the meat, poultry and seafood segments, such as texturants and marinades, among other offerings, and was built in the thriving Zhangjiagang Free Trade Zone, which is located in the heart of the Greater Shanghai area. ICL will leverage the new facility to continue servi
Expanded Board Enhances Financial and Governance Expertise Supporting ESG Commitments REE Automotive Ltd. (NASDAQ:REE), a leader in e-mobility, announced today that it has expanded its Board of Directors, appointing two new independent members. The additional board members deepen and diversify its leadership as the company progresses towards technology maturation and commercial production in 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211026005784/en/Michal Brikman (Photo: Business Wire) REE has appointed seasoned veterans Ms. Michal Brikman and Ms. Lilach Geva-Harel, who bring a wealth of public company financial, corp
TEL AVIV, Israel, Nov. 21, 2024 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its third quarter results for the period ending September 30, 2024. Selected Financial Figures for the Third Quarter 2024: $m Q3/24 Q3/23 ILCO share in ICL profit1 49 59 Financing income, G&A and other expenses at ILCO headquarter level - (1) Tax income of ILCO Headquarters - - Net profit to company's shareholders 49 58 Liquidity at the ILCO Headquarters Level2 As of September 30, 2024, total financial liabilities were $722 million, and investments in liquid assets amounted to $843 million of which $313 million are pledged deposits. Net cash1 as of September 30, 2024, totaled $84
Continued to deliver sequential growth, with sales of $1.8 billion and adjusted EBITDA of $383 million Raising guidance for specialties-driven businesses ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2024. Consolidated sales were $1.75 billion versus $1.86 billion in the prior year. Operating income was $214 million, with adjusted operating income of $243 million, versus $227 million of operating income in the third quarter of last year. Adjusted EBITDA was $383 million versus $346 million. Diluted earnings per share were $0.09, with adjusted diluted EPS of $0.11, versus $0.11 in the
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2024 results prior to the opening of the TASE market on Monday, November 11, 2024. On that day, Raviv Zoller, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 225-9448, or (203) 518-9708 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employee
More than one dozen novel microbes identified for row crops suffering from extreme weather conditionsTEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viability as bio-stimulants for crops grown und
ICL Group (NYSE:ICL) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 60.87 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $1.735 billion which missed the analyst consensus estimate of $1.752 billion by 0.95 percent. This is a 18.01 percent decrease over sales of $2.116 billion the same period last year.
Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:ICL) with a Underweight and raises the price target from $4 to $4.5.